Anticoagulation Resources for Healthcare Professionals
Resources, (Miscellaneous)
- Anticoagulation, About Us Clinic News
- Anticoagulation Dosing
- Anticoagulation Education Documentation in MPER
- Assessment of the Risk of Bleeding During Anticoagulation Therapy
- GPIIb/IIIa Bridge When Holding an Oral Antiplatelet Agent
- Guidelines for Antithrombin Use
- Heparin Induced Thrombocytopenia (HIT) Assessment
- Primary Decision Support Tool for Suspected Heparin-Induced Thrombocytopenia
- Venous Thromboembolism Clinical Algorithm
- VTE Risk Assessment Tool
Bivalirudin
Dental Procedures
Discharging Patients
Neuraxial Anesthesia
Reversal of Anticoagulants
VIIa (rFVIIa)
- Recombinant Factor VIIa (rFVIIa) in Acute CNS Hemorrhage
- Recombinant Factor VIIa in Congential Cardiac Surgery
- Recombinant Activated Factor VII (rFVIIa) in Adult Cardiothoracic Surgery
- Recombinant Activated Factor VII (rFVIIa) in Neurosurgical Patients for Prophylaxis of Intracranial Intervention
- Prothrombin Complex Concentrate (PCC4) and Recombinant Activated Factor VII (rFVIIa) in Adult Trauma Patients With Acute Life Threatening Bleeding Without Anticoagulation-Related Intracranial Hemorrhage and Not Currently Receiving Tranexamic Acid
Warfarin (Coumadin®)
- Warfarin (Coumadin®) Provider Agreement - Chinese
- Warfarin (Coumadin®) Provider Agreement - English
- Warfarin (Coumadin®) Provider Agreement - Hmong
- Warfarin (Coumadin®) Provider Agreement - Russian
- Warfarin (Coumadin®) Provider Agreement - Spanish
- Warfarin (Coumadin®) Provider Agreement - Vietnamese